Dr. Christoph Huber, Chief Scientific Officer, Anaveon AG, Technologiepark Basel, Basel, Switzerland

Development of an engineered IL-2 cytokine for the treatment of cancer

Seminars on Drug Sciences (SDS)

All seminars on Drug Sciences this semester will be online via Zoom.
Link for lecture with Manuela Rogalski (manuela.rogalski@unibas.ch) till Wednesdays 11:30 a.m.